Andrew Saunders
Direttore Tecnico/Scientifico/R&S presso CellCentric Ltd.
Profilo
Andrew Saunders is currently the Chief Medical Officer at CellCentric Ltd.
He previously worked as the Managing Director at Linden Oncology Ltd.
and as the Chief Medical Officer at Bioenvision, Inc. and Lytix Biopharma AS.
He also served as the Co-Chief Medical Officer at Redx Pharma Plc from 2018 to 2021.
Dr. Saunders earned a doctorate degree from Trinity College Dublin in 1989.
Posizioni attive di Andrew Saunders
Società | Posizione | Inizio |
---|---|---|
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Andrew Saunders
Società | Posizione | Fine |
---|---|---|
REDX PHARMA PLC | Direttore Tecnico/Scientifico/R&S | 01/03/2021 |
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Direttore Tecnico/Scientifico/R&S | 09/04/2007 |
Linden Oncology Ltd. | Amministratore Delegato | - |
LYTIX BIOPHARMA | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Andrew Saunders
Trinity College Dublin | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
LYTIX BIOPHARMA | Health Technology |
REDX PHARMA PLC | Health Technology |
Aziende private | 3 |
---|---|
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Health Services |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Linden Oncology Ltd. |
- Borsa valori
- Insiders
- Andrew Saunders